Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | AVZO-103 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on AVZO-103, a putative bispecific antibody targeting Nectin4 and Trop2 (Sep 2025). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| AVZO-103 | AVZO103|AVZO 103 | TROP2 Antibody 18 | Limited information is currently available on AVZO-103, a putative bispecific antibody targeting Nectin4 and Trop2 (Sep 2025). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07193511 | Phase Ib/II | AVZO-103 | Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001) | Recruiting | USA | 0 |